fluorodeoxyglucose f18 has been researched along with Soft Tissue Neoplasms in 196 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.51) | 18.7374 |
| 1990's | 15 (7.65) | 18.2507 |
| 2000's | 80 (40.82) | 29.6817 |
| 2010's | 77 (39.29) | 24.3611 |
| 2020's | 23 (11.73) | 2.80 |
| Authors | Studies |
|---|---|
| Batus, M; Blank, AT; Colman, MW; Gitelis, S; Kazmer, A; Lee, L | 1 |
| Cheng, C; Dong, A; Yang, Q; Zhang, Z; Zuo, C | 1 |
| Karakousis, GC; Sharon, CE; Straker, RJ | 1 |
| Mendoza, H; Nosov, A; Pandit-Taskar, N | 1 |
| Dong, K; Dong, M; Fu, J; Guanghua, W; Jiang, T; Li, C; Zheng, H; Zhou, S | 1 |
| Cui, F; Hou, W; Li, L; Li, Q; Ma, B; Ren, Y; Su, M; Sun, X; Tian, R; Wu, M; Xu, J; Zou, K | 1 |
| Chen, H; Dai, J; Gao, F; Tian, R | 1 |
| Abu-Hijleh, HA; Abualruz, A; Aldahamsheh, OO; Thalib, L; Younis, MH | 1 |
| Abe, S; Ishida, T; Kaminaga, T; Kikuchi, Y; Yamamoto, A | 1 |
| Deng, J; Guo, S; Kong, W; Shi, Y; Zeng, W | 1 |
| Ejilemele, AA; Nava, VE | 1 |
| Errani, C; Mavrogenis, AF; Tanaka, Y; Tsukamoto, S | 1 |
| Chen, B; Feng, H; Li, C; Wang, S; Xie, J; Zhang, Y | 1 |
| Kamai, T; Kijima, T; Owada, A; Suzuki, I | 1 |
| Farahmandfar, F; Moradian, S; Sadeghi, R; Shahlaei, S; Shakeri, S | 1 |
| Browning, MB; Kumbhar, SS; Qi, J; Thakrar, PD; Vo, N | 1 |
| Allende Riera, AJ; Cabello García, D; Díaz Silván, A; Lara Martínez, MF; Vilahomat Hernández, O | 1 |
| Beets-Tan, R; Bodalal, Z; Bruining, A; Colombo, P; Gennaro, N; Haas, R; Messiou, C; Reijers, S; van der Graaf, WTA; van Houdt, W | 1 |
| Bozkurt, MF; Soydas Turan, B | 1 |
| Shen, G; Tian, R; Wang, R | 1 |
| Boujida, I; El Aoufir, O; Ghannam, A; Horache, K; Jerguigue, H; Latib, R; Omor, Y | 1 |
| Benz, MR; Crompton, JG; Harder, D | 1 |
| Chen, Y; Deng, J; Lan, L; Liu, H; Qiu, L | 1 |
| Bagatell, R; Berthold, F; Boubaker, A; Brock, P; Burchill, S; Cohn, SL; Ladenstein, R; Lindwasser, OW; London, WB; Maris, JM; Matthay, KK; McHugh, K; Nuchtern, JG; Park, JR; Pearson, AD; Schleiermacher, G; Seibel, NL; Valteau-Couanet, D; Villablanca, JG | 1 |
| Servaes, SE; Tolboom, N; Zhuang, H | 1 |
| Cui, Z; Feng, X; Guan, H; Hu, W; Liu, X; Peng, J; Su, Z; Wang, W; Wang, Z; Wu, F; Wu, S; Yang, J; Zhao, C; Zhao, H | 1 |
| Bauer, S; Erfanian, Y; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Podleska, LE; Poeppel, T; Umutlu, L; Wetter, A | 1 |
| Borrego-Dorado, I; de Bonilla-Damiá, A; Fernández-López, R; Márquez-Vega, C; Pachón-Garrudo, VM | 1 |
| Honda, H; Hong, S; Kamei, R; Kawanami, S; Matsumoto, Y; Sagiyama, K; Watanabe, Y | 1 |
| Albano, D; Bertagna, F; Bosio, G; Giubbini, R; Treglia, G | 1 |
| Asano, Y; Fujita, H; Kadono, T; Masui, Y; Miyagawa, T; Saigusa, R; Sato, S; Yamada, D | 1 |
| Davidson, DJ; Elojeimy, S; Favinger, JL; Ha, AS; Hippe, DS; Lindberg, AW; Roth, ES | 1 |
| He, Y; Li, C; Shen, M; Tian, Y; Wen, B | 1 |
| Liu, Y | 1 |
| Choi, BW; Jeon, JC; Kang, S; Won Kim, H | 1 |
| Abe, K; Aiba, H; Hayashi, K; Higuchi, T; Igarashi, K; Ikeda, H; Inatani, H; Miwa, S; Mochizuki, T; Shirai, T; Takeuchi, A; Taniguchi, Y; Tsuchiya, H; Yamamoto, N | 1 |
| Athanasou, NA; Iwata, E; Orosz, Z; Reynolds, J; Tanaka, Y; Teh, J; Whitwell, D | 1 |
| Bozkurt, M; Çayir, D; Gültekin, SS; Karaçalioğlu, AÖ | 1 |
| Cao, L; Chen, F; Li, S; Lin, S; Yang, F | 1 |
| de Haas, RJ; de Jong, KP; Dierckx, RAJO; Kwee, TC; Murshid, KJA; Pennings, JP | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Kim, BT; Lee, KH; Lim, CH; Moon, SH; Seok, HY | 1 |
| Cotton, F; Fontaine Hommell, J; Ognong Boulemo, A; Ricard, F; Roch, JA | 1 |
| Ahlawat, S; Belzberg, A; Blakeley, J; Fayad, LM; Montgomery, E; Subramaniam, RM | 1 |
| Hickeson, M; Holcroft, C; Makis, W; Nahal, A; Rakheja, R; Skamene, S; Tulbah, R; Turcotte, R | 1 |
| Aoki, M; Iwasaki, H; Nabeshima, K; Naito, M; Nishio, J | 1 |
| Califano, I; Califano, L; Coduti, M; Otero, J; Quildrian, S; Rojas Bilbao, E | 1 |
| Harada, M; Iwamoto, S; Nose, H; Otomi, Y; Otsuka, H; Takao, S; Terazawa, K | 1 |
| Amstalden, EM; Etchebehere, EC; Etchebehere, M; Kalaf, G; Leal, AL; Pacheco, EB; Santos, AO | 1 |
| Conrad, EU; Eary, JF; Hawkins, DS; O'Sullivan, F; O'Sullivan, J; Schuetze, SM | 1 |
| Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Rusca, T; Treglia, G | 1 |
| Andreou, D; Boldt, H; Jobke, B; Pink, D; Reichardt, P; Schuler, M; Tunn, PU; Werner, M | 1 |
| Juan, YH; Khandelwal, A; Krajewski, KM; Ramaiya, N; Saboo, SS; Shinagare, AB; Tirumani, SH | 1 |
| Le, BB; Nguyen, BD | 1 |
| Doran, MG; Fareedy, SB; Gavane, S; Osborne, JR; Spratt, DE; Tarlinton, L; Zelefsky, MJ | 1 |
| Jing, Y; Niu, JH; Sun, L; Yang, H; Yao, ZL; Yu, L; Zhang, Q; Zhu, CY; Zhu, HY | 1 |
| Chagawa, K; Hirano, Y; Kido, S; Muramatsu, K; Suga, K; Tachibana, R; Tanaka, S; Xu, R | 1 |
| Choi, YY; Kim, JY; Lee, S; Paik, SS; Park, J | 1 |
| Harish, K; Maka, V | 1 |
| Chalian, M; Fergus, N; Kosmas, C; Mansoori, B; Partovi, S; Robbin, MR; Ros, PR; Zipp, L | 1 |
| Bartenstein, P; Chalkidis, RP; Cyran, CC; Fendler, WP; Hacker, M; Herrmann, K; Ilhan, H; Issels, RD; Knösel, T; Lindner, LH | 1 |
| Boriani, S; Cappelli, A; Fanti, S; Gasbarrini, A; Golfieri, R; Graziani, T; Guidalotti, P; Nanni, C; Sandler, I | 1 |
| Boellaard, R; Collette, S; Dewji, R; Hristova, I; Marreaud, S; Mottaghy, F; Oyen, WJ; Sanfilippo, R; Schöffski, P; van der Graaf, W; Vogel, W | 1 |
| Hafezi-Nejad, N; Marcus, C; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| Andersen, KF; Fuglo, HM; Loft, A; Petersen, MM; Rasmussen, SH | 2 |
| Adam, G; Derlin, T; Mautner, VF; Salamon, J | 1 |
| Kiyohara, H; Nakano, T; Ohno, T; Saito, K; Takagishi, K; Yanagawa, T | 1 |
| Dämmrich, M; Derlin, T; Koestner, W | 1 |
| Furuta, T; Johan, MP; Kubo, T; Ochi, M | 1 |
| Chen, G; Liao, JQ; Wang, SX; Wang, SY | 1 |
| Ben-Haim, S; Chikman, B; Davidson, T; Eshed, I; Goldstein, J; Goshen, E | 1 |
| Aktas, GE; Demir, SS; Oz Puyan, F; Sarikaya, A | 1 |
| Cheng, YS; Dai, YL; Li, YJ; Tu, CQ; Zhang, WB | 1 |
| Basso, U; Burei, M; Evangelista, L | 1 |
| Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A | 1 |
| Dolak, W; Karanikas, G; Kiesewetter, B; Kletter, K; Lukas, J; Mayerhoefer, ME; Müllauer, L; Pones, M; Raderer, M; Rausch, I; Simonitsch-Klupp, I; Weber, M | 1 |
| Baroli, A; Crivelli, F; Gilardi, L; Lomuscio, G; Vadrucci, M | 1 |
| Hope, TA; Kaushik, SS; Larson, PE; Leynes, AP; Seo, Y; Shanbhag, DD; Wiesinger, F; Yang, J | 1 |
| Bek, CS; Kim, HW; Song, BI; Won, KS | 1 |
| Chen, L; Guo, L; Li, Q; Ma, X; Wu, X; Zhu, C | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Eilber, FC; Evilevitch, V; Phelps, ME; Weber, WA | 1 |
| Charest, M; Derbekyan, V; Hickeson, M; Novales, JA; Singnurkar, A | 1 |
| Arai, K; Hirahashi, M; Iwamoto, Y; Jono, O; Oya, M; Sakamoto, A | 1 |
| Cho, IH; Choi, JH; Chun, KA; Han, DS; Shin, DS; Shon, OJ | 1 |
| Hicks, RJ; Kim, PJ; Mac Manus, MP; Prince, HM; Ryan, G; Seymour, JF; Wirth, A | 1 |
| Fukuda, H; Hosono, A; Inoue, T; Kaneta, T; Kim, EE; Makimoto, A; Murakami, K; Nakamoto, Y; Suga, T; Tateishi, U; Terauchi, T | 1 |
| Henderson, R; Ho, L; Seto, J; Wassef, H | 1 |
| Allen-Auerbach, MS; Benz, MR; Chow, K; Czernin, J; Dry, SM; Eckardt, JJ; Eilber, FC; Elashoff, D; Evilevitch, V; Phelps, ME; Tap, WD; Weber, WA | 1 |
| Bischoff, G; Bischoff, M; Buck, A; Gebhard, F; Pauls, S; Reske, SN; Scheffold, F; Schultheiss, M; von Baer, A | 1 |
| Evanson, J; Kelly, PA; Metcalfe, K; Monson, JP; Plowman, PN; Sabin, I | 1 |
| Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
| Landa, J; Schwartz, LH | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
| Choe, JG; Kang, CH; Kim, CH; Noh, W; Park, EK; Park, JH | 1 |
| Exner, UG; Strobel, K; von Hochstetter, AR | 1 |
| Araki, N; Emori, M; Fujimoto, T; Hamada, K; Joyama, S; Naka, N; Nakanishi, K; Omori, S; Tomita, Y | 1 |
| Iizuka, Y; Shinozaki, T; Takagishi, K; Watanabe, H; Yanagawa, T | 1 |
| Amann, K; Behzad, A; Linke, R; Mackensen, A; Müller, A; Rösler, W | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Dry, SM; Eilber, FC; Elashoff, D; Phelps, ME; Tap, WD | 1 |
| Franzius, C | 1 |
| Kitajima, K; Maeda, T; Ohno, Y; Onishi, Y; Sakamoto, S; Senda, M; Sugimura, K; Suzuki, K; Yoshikawa, T | 1 |
| Kawaguchi, Y; Kawase, Y; Maeda, Y; Nishiyama, Y; Yamamoto, Y | 1 |
| Arishima, Y; Komiya, S; Nagano, S; Tanimoto, A; Terahara, M; Yokouchi, M; Yoshioka, T; Zemmyo, M | 1 |
| Gutzeit, A; Jacob, AL; Kos, S; Menter, T; Schubert, T; Takes, M | 1 |
| Ennis, F; Inneh, IA; Lee, MS; Simon, SL; Sullivan, S | 1 |
| Hain, SF; Khan, S; Stevenson, W | 1 |
| Allen-Auerbach, M; Czernin, J; Dunkelmann, S; Federman, N; Hall, T; Walter, F; Walter, MA | 1 |
| Padhy, AK; Tan, ML | 1 |
| Blaise, C; Bravetti, P; Dolivet, G; Gallet, P; Graff, P; Henrot, P; Huger, S; Leroux, A; Marie, PY; Merlin, JL; Phulpin, B; Pinel, S; Poussier, S; Tran, N | 1 |
| Garg, PK; Kumar, A | 1 |
| Kleijnen, J; Paschen, U; Sauerland, S; Westwood, M; Wolff, R | 1 |
| Hayashi, A; Hiruta, N; Inaoka, T; Kudo, H; Nakagawa, K; Terada, H; Tokuyama, W | 1 |
| Aydin, T; Mulazimoglu, M; Tamam, MO | 1 |
| Nguyen, BD; Nguyen, VX | 1 |
| Akhurst, T; Etchebehere, EC; Gonen, M; Humm, K; Larson, SM; Macapinlac, HA; Scher, HI; Yeung, HW | 1 |
| Becker, I; Herz, M; Krüger, A; Rau, FC; Schwaiger, M; Senekowitsch-Schmidtke, R; Weber, WA; Wester, HJ | 1 |
| Bruckner, JD; Chandhury, KR; Conrad, EU; Eary, JF; O'Sullivan, F; Powitan, Y; Vernon, C | 1 |
| Bruns, J; Dobrowolskij, D; Jenicke, L; Niggemeyer, O | 1 |
| Bergh, S; Boerner, AR; Brunkhorst, T; Gratz, FW; Knapp, WH; Otto, D | 1 |
| Bredella, MA; Caputo, GR; Steinbach, LS | 1 |
| Cohade, C; Osman, M; Pannu, HK; Wahl, RL | 1 |
| Aoki, J; Endo, K; Koyama, Y; Sato, N; Shinozaki, T; Takagishi, K; Tokunaga, M; Watanabe, H | 1 |
| Conrad, EU; Eary, JF; Rubin, BP; Schuetze, S; Vernon, CB | 1 |
| Aoki, J; Endo, K; Higuchi, T; Oriuchi, N; Tanada, S; Tian, M; Watanabe, H; Zhang, H | 1 |
| Bruckner, JD; Chin, LK; Conrad, EU; Eary, JF; Grierson, JR; Hofstrand, PD; Krohn, KA; Peterson, LM; Rajendran, JG; Rasey, JS; Wilson, DC | 1 |
| Feldman, F; Manos, C; van Heertum, R | 1 |
| Ahmed, AR; Aoki, J; Endo, K; Shinozaki, T; Takagishi, K; Watanabe, H; Yanagawa, T | 1 |
| Adler, LP; Israel-Mardirosian, N | 1 |
| Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, M; Strauss, LG; Willeke, F | 1 |
| Bingham, J; Chinyama, C; Hain, SF; O'Doherty, MJ; Smith, MA | 1 |
| Carreras-Delgado, JL; Hornedo-Muguiro, J; Lapeña-Gutiérrez, L; Montz-Andrée, R; Pérez-Castejón, MJ; Ruíz-Hernández, G; Salinas-Hernández, P | 1 |
| Bastiaannet, E; Cobben, DC; Groen, H; Hoekstra, HJ; Jager, PL; Vaalburg, W; van der Graaf, WT | 1 |
| Blank, A; Bokstein, F; Even-Sapir, E; Lerman, H; Lievshitz, G; Metser, U | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Beaulieu, S; Conrad, E; Djang, D; Eary, JF; Rubin, B; Turcotte, E | 1 |
| Conti, PS; Gamie, S; Jadvar, H; Ramanna, L | 1 |
| Bruckner, JD; Conrad, EU; Eary, JF; Hawkins, DS; Rubin, BP; Schuetze, SM; Vernon, C | 1 |
| Büchler, MW; Cardona, S; Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, MH; Strauss, LG; Willeke, F | 1 |
| Conrad, EU; Eary, JF; Morgan, HD; Schuetze, SM; Vernon, C | 1 |
| Nguyen, BD | 1 |
| Mansberg, R; Mansberg, V; Nguyen, QH; Szeto, E | 1 |
| Basu, S; Nair, N | 1 |
| Börner, AR; Knapp, WH; Mirzayan, MJ; Petrich, T; Samii, A; Samii, M | 1 |
| Breidahl, W; Patrikeos, A; Robins, P | 1 |
| Caride, VJ; Wasyliw, CW | 1 |
| Hamada, K; Hatazawa, J; Tomita, Y; Ueda, T; Yoshikawa, H | 1 |
| Golan, H; Linchinsky, O; Melloul, M; Volkov, O | 1 |
| Baghel, NS; Malhotra, G; Moghe, SH; Nair, N | 1 |
| Bar Shalom, R; Ben Arush, MW; Haimi, M; Israel, O; Militianu, D; Postovsky, S; Zaidman, I | 1 |
| Chivers, SF; Nguyen, BD | 1 |
| Gambhir, SS; Iagaru, A; McDougall, IR; Quon, A | 1 |
| Arai, Y; Hamashima, C; Kim, EE; Maeda, T; Moriyama, N; Sugimura, K; Tateishi, U; Terauchi, T | 1 |
| Enomoto, K; Hamada, K; Hatazawa, J; Higuchi, I; Kakunaga, S; Myoui, A; Tomita, Y; Ueda, T; Yoshikawa, H | 1 |
| Nguyen, BD; Ram, PC; Roarke, MC | 1 |
| de Llano, SR; Mahmood, S | 1 |
| Al-Kutoubi, A; Arabi, M; Kinge, AR; Otrock, ZK; Shamseddine, A | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Antonescu, C; Bilsky, MH; Boland, PJ; Healey, JH; Schwab, JH | 1 |
| Nguyen, BD; Wiesenthal, AA | 1 |
| Arai, Y; Kim, EE; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U | 1 |
| Chaar, BT; Nguyen, NC; Osman, MM | 1 |
| Chawla, SP; Conti, PS; Fedenko, A; Iagaru, A; Masamed, R; Menendez, LR | 1 |
| Bredella, MA; Kattapuram, S; Nielsen, GP; Ouellette, HA; Sheah, K; Torriani, M | 1 |
| Peterson, JJ | 1 |
| Colomo, L; Combalia-Aleu, A; Conill, C; Marruecos, J; Maurel, J; Palacín, A; Pomés, J; Setoain, X; Vargas, M | 1 |
| Ames, D; Bharija, A; Mantil, J; Pelstring, R; Percy, T; Rehani, B; Scheler, J | 1 |
| Hoekstra, HJ; Nieweg, OE; Oldhoff, J; Paans, AM; Pruim, J; Schraffordt Koops, H; Vaalburg, W | 1 |
| Gross, MD; Grossman, HB; Shreve, PD; Wahl, RL | 1 |
| Hoekstra, HJ; Koops, HS; Molenaar, WM; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
| Hoekstra, HJ; Koops, HS; Molenaar, WM; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ; Willemsen, AT | 1 |
| Brizel, DM; Charles, HC; Coleman, RE; Dewhirst, MW; Friedman, HS; Harrelson, JM; Jones, DN; Layfield, L; McCowage, GB; Prescott, DM; Scully, SP; Sostman, HD | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Adler, LP; Faulhaber, P; Miraldi, F | 1 |
| Bruckner, JD; Conrad, EU; Eary, JF; Folpe, A; Howlett, AT; Hunt, KJ; Mankoff, DA | 1 |
| Bingham, JB; Fletcher, CD; Lucas, JD; McKee, PH; O'Doherty, MJ; Smith, MA; Wong, JC | 1 |
| Cronin, BF; Lodge, MA; Lucas, JD; Marsden, PK; O'Doherty, MJ; Smith, MA | 1 |
| Hoekstra, HJ; Kole, AC; Molenaar, WM; Plaat, BE; Vaalburg, W | 1 |
| Brecht-Krauss, D; Diederichs, CG; Guhlmann, A; Hartwig, E; Heymer, B; Kotzerke, J; Reske, SN; Sarkar, MR; Schulte, M; Schultheiss, M | 1 |
| Attigah, N; Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, MH; Strauss, LG; Willeke, F; Zhang, YM | 1 |
| Conrad, EU; Eary, JF; Folpe, AL; Lyles, RH; Sprouse, JT | 1 |
| O'Doherty, MJ; Smith, MA | 1 |
| Aoki, J; Endo, K; Inoue, T; Mohara, S; Sano, K; Shinozaki, T; Takagishi, K; Tokunaga, M; Watanabe, H; Yanagawa, T | 1 |
| Benard, F; Boileau, R; Mongeau, CJ; Turcotte, E; Verreault, J | 1 |
| Abdel-Dayem, HM; el-Zeftawy, H; Heiba, SI; Jana, S; Rosen, G; Salem, S; Santiago, JF | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Heichel, T; Lehnert, T; Mechtersheimer, G; Schwarzbach, M; Strauss, LG; Willeke, F | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Yeung, HW | 1 |
| Haberkorn, U | 1 |
| Bockisch, A; Franzius, C; Hillmann, A; Jürgens, H; Schober, O; Schulte, M; Winkelmann, W | 1 |
| Akhurst, T; Cai, S; Gonen, M; Larson, SM; Macapinlac, HA; Nuñez, R; Osman, I; Riedel, E; Scher, HI; Yeung, HW | 1 |
| Conte, PF; Dani, D; Donati, S; Gennari, A; Giorgetti, A; Landucci, E; Mariani, G; Pisani, P; Poli, M; Puccini, G; Salvadori, B; Salvadori, PA; Sorace, O | 1 |
| Chatterton, BE; Cohen, P; Coventry, BJ; Mensforth, D | 1 |
| Akhurst, T; Larson, SM; Macapinlac, H; Morris, MJ; Nunez, R; Osman, I; Scher, HI; Schwartz, L; Siedlecki, K; Verbel, D | 1 |
| Dehdashti, F; Griffeth, LK; McGuire, AH; McGuire, DJ; Moerlein, SM; Perry, DJ; Siegel, BA | 1 |
| Adler, LP; al-Kaisi, N; Blair, HF; Joyce, MJ; Leisure, G; Makley, JT; Miraldi, F; Williams, RP | 1 |
| Brunetti, A; Chang, AE; Finn, RD; Kern, KA; Lack, E; Larson, SM; Malawer, M; Norton, JA; Rosenberg, SA | 1 |
24 review(s) available for fluorodeoxyglucose f18 and Soft Tissue Neoplasms
| Article | Year |
|---|---|
The Role of Imaging in Soft Tissue Sarcoma Diagnosis and Management.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2022 |
Molecular imaging of sarcomas with FDG PET.
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2023 |
Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2020 |
Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand?
Topics: Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 2021 |
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2021 |
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Consensus; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2017 |
Neuroendocrine Tumor Arising in a Tailgut Cyst: A Rare Presacral Tumor.
Topics: Adult; Biopsy; Cysts; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hamartoma; Humans; Magnetic Resonance Imaging; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Sacrococcygeal Region; Soft Tissue Neoplasms | 2019 |
Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed | 2014 |
Magnetic resonance/positron emission tomography (MR/PET) oncologic applications: bone and soft tissue sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2014 |
Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Topics: Adult; Cell Transformation, Neoplastic; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
Topics: Bone Neoplasms; Chi-Square Distribution; Fluorodeoxyglucose F18; Humans; Odds Ratio; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 2016 |
Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
Topics: Bone Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tumor Burden | 2016 |
Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Sarcoma; Soft Tissue Neoplasms | 2017 |
FDG-PET/CT in pediatric solid tumors.
Topics: Bone Neoplasms; Brain Neoplasms; Child; Fluorodeoxyglucose F18; Hepatoblastoma; Histiocytosis, Langerhans-Cell; Humans; Liver Neoplasms; Neoplasms; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2010 |
FDG-PET for evaluating musculoskeletal tumors: a review.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography of soft tissue sarcomas.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Tomography, Emission-Computed | 2004 |
Musculoskeletal system.
Topics: Bone Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Soft Tissue Neoplasms | 2004 |
F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2007 |
PET imaging in soft tissue sarcomas.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1997 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group].
Topics: Age Factors; Bone Neoplasms; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
8 trial(s) available for fluorodeoxyglucose f18 and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Young Adult | 2014 |
Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Extremities; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2011 |
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Cervical Vertebrae; Extremities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Lumbar Vertebrae; Male; Pelvis; Phantoms, Imaging; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Ribs; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.
Topics: Adult; Aged; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Neoplasm Staging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Vascular Endothelial Growth Factor A | 2003 |
Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?
Topics: Adult; Aged; Algorithms; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Surgery, Computer-Assisted; Treatment Outcome | 2003 |
Malignant involvement of the spine: assessment by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Compression Syndromes; Polyradiculopathy; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Soft Tissue Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Spinal Nerve Roots; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms | 2004 |
164 other study(ies) available for fluorodeoxyglucose f18 and Soft Tissue Neoplasms
| Article | Year |
|---|---|
PET-CT staging affects time to treatment in sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Time-to-Treatment | 2022 |
68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in a Case With Intimal Sarcoma of the Pulmonary Artery.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Quinolines; Sarcoma; Soft Tissue Neoplasms | 2022 |
The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report.
Topics: Aged; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kidney Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden | 2023 |
Quality and consistency of clinical practice guideline recommendations for PET/CT and PET: a systematic appraisal.
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2023 |
Right Adrenocortical Carcinoma Coexisting With Left Adrenal Sarcomatoid Carcinoma on FDG PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoma; Soft Tissue Neoplasms | 2023 |
High FDG Uptake in Pleomorphic Hyalinizing Angiectatic Tumor.
Topics: Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2020 |
Fusion of FDG-PET Image and Clinical Features for Prediction of Lung Metastasis in Soft Tissue Sarcomas.
Topics: Adult; Aged; Computational Biology; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2020 |
Topics: Adult; Animals; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Onchocerca volvulus; Onchocerciasis; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2020 |
Imaging of Soft Tissue Tumors.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2021 |
Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Topics: Adult; Aged; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; ROC Curve; Sarcoma; Soft Tissue Neoplasms; Tumor Burden | 2020 |
Case of prostate stromal tumour of uncertain malignant potential where positron emission tomography with 18F-fluorodeoxyglucose was useful for surgical planning.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Robotic Surgical Procedures; Soft Tissue Neoplasms | 2020 |
Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Muscle, Skeletal; Pancreatic Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms | 2020 |
Clinical utilization of whole-body PET/MRI in childhood sarcoma.
Topics: Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2021 |
18F-FDG PET/CT Assessment of Malignant Granular Cell Tumor of the Soft Tissue.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2021 |
Unusual Presentation of Herpes Zoster Infection Mimicking Soft Tissue Metastases of Breast Cancer on 18F-FDG PET/CT Imaging.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Herpes Zoster; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2021 |
FDG PET/CT Findings of a Primary Paravertebral Liposarcoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liposarcoma; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Soft Tissue Neoplasms | 2022 |
[Bilateral dorsal masses].
Topics: Fibroma; Fluorodeoxyglucose F18; Humans; Soft Tissue Neoplasms | 2021 |
68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Quinolines; Soft Tissue Neoplasms; Stomach | 2022 |
Neuroblastoma Presenting as Non-MIBG-Avid Widespread Soft Tissue Metastases Without Bone Involvement Revealed by FDG PET/CT Imaging.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2017 |
Philadelphia chromosome-positive acute myeloid leukemia with masses and osteolytic lesions: finding of 18F-FDG PET/CT.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Osteolysis; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2017 |
Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2017 |
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms | 2018 |
Multiparametric voxel-based analyses of standardized uptake values and apparent diffusion coefficients of soft-tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tumor Burden | 2017 |
18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plasmacytoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Soft Tissue Neoplasms | 2018 |
Lymphangiosarcoma of the hip arising in a congenital non-irradiated lymphangioma.
Topics: Adult; Biopsy; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fluorodeoxyglucose F18; Hip; Humans; Lymphangioma; Lymphangiosarcoma; Neoplasms, Second Primary; Positron-Emission Tomography; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2017 |
Soft Tissue Sarcoma Response to Two Cycles of Neoadjuvant Chemotherapy: A Multireader Analysis of MRI Findings and Agreement with RECIST Criteria and Change in SUVmax.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Treatment Outcome | 2018 |
Mixed Epithelial and Stromal Tumor of the Kidney Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Breast Cancer.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Neoplasms, Complex and Mixed; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2018 |
Images in Vascular Medicine: Septic and tumor thrombosis caught by inferior vena cava filters and demonstrated on FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prosthesis Implantation; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Squamous Cell Carcinoma of Head and Neck; Vena Cava Filters; Venous Thrombosis | 2018 |
Nodular fasciitis mimicking malignant soft tissue tumor in an infant, with 18F-FDG PET/CT findings: A case report.
Topics: Diagnosis, Differential; Ear Canal; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Infant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2018 |
Efficacy and Limitations of F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography to Differentiate Between Malignant and Benign Bone and Soft Tissue Tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Young Adult | 2018 |
Earlier Phases of Bone Scintigraphy Can Better Delineate the Extent of Soft Tissue Involvement of Bone Metastasis.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Technetium Tc 99m Medronate | 2018 |
Hemosiderotic Fibrolipomatous Tumor on FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2019 |
FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Chemoradiotherapy, Adjuvant; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proctectomy; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; ROC Curve; Sacrum; Soft Tissue Neoplasms | 2019 |
Evaluation of a diagnostic
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Soft Tissue Neoplasms | 2019 |
Hibernoma: don't be caught out by a PET scan!
Topics: Adipose Tissue; Aged; Biopsy, Fine-Needle; Buttocks; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Image-Guided Biopsy; Imaging, Three-Dimensional; Lipoma; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Neoplasms, Multiple Primary; Positron-Emission Tomography; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2013 |
Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.
Topics: Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Multiple Primary; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms | 2013 |
Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2013 |
FDG PET/CT findings of superficial angiomyxoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myxoma; Positron-Emission Tomography; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2014 |
Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.
Topics: Adenocarcinoma, Papillary; Adult; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Correlations between F-18 FDG PET/CT and pathological findings in soft tissue lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma; Magnetic Resonance Imaging; Male; Middle Aged; Neurilemmoma; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2014 |
Multifocal epithelioid hemangioendothelioma of the lower limbs detected by 18F-FDG PET/MRI.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Leg; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Vascular Neoplasms | 2014 |
Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
Topics: Aged; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Lower Extremity; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasms, Second Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Utility of FDG-PET in clinical neuroendocrine prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Prevalence; Prostatic Neoplasms; Retrospective Studies; Soft Tissue Neoplasms | 2014 |
[Analysis of (18)F-FDG PET/CT features and clinical manifestations in one case of subcutaneous lymphomatoid granulomatosis].
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymphomatoid Granulomatosis; Male; Positron-Emission Tomography; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2014 |
Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
Topics: Area Under Curve; Bone and Bones; Bone Neoplasms; Diagnosis, Computer-Assisted; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Soft Tissue Neoplasms; Support Vector Machine; Tomography, X-Ray Computed | 2014 |
Nodular fasciitis mimicking soft tissue metastasis on 18F-FDG PET/CT during surveillance.
Topics: Adult; Diagnosis, Differential; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Multiple chest wall swellings in adult Burkitt's lymphoma.
Topics: Bone Neoplasms; Burkitt Lymphoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Sternum; Thoracic Wall; Tomography, X-Ray Computed | 2014 |
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
FDG PET/CT for bone and soft-tissue biopsy.
Topics: Adult; Bone Neoplasms; Chordoma; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial.
Topics: Clinical Trials, Phase III as Topic; Fluorodeoxyglucose F18; Guidelines as Topic; Humans; Multicenter Studies as Topic; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms | 2015 |
Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Denmark; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radionuclide Imaging; Retrospective Studies; ROC Curve; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2015 |
Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
[Not Available].
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2016 |
18F-FDG PET/CT and Contrast-Enhanced CT of Primary Malignant Tracheal Tumor.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tracheal Neoplasms | 2016 |
Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Scapula; Sensitivity and Specificity; Soft Tissue Neoplasms; Tumor Burden | 2016 |
Incidental Detection of Subcutaneous Myopericytoma of Trunk on FDG PET/CT and Bone Scintigraphy for Imaging of Colon Cancer.
Topics: Bone Neoplasms; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Torso | 2016 |
A Solitary Metastasis for a Malignant Schwannoma in the Gallbladder Detected by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Middle Aged; Neurilemmoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2016 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Soft Tissue Neoplasms | 2016 |
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Diffusion Magnetic Resonance Imaging; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunotherapy; Lacrimal Apparatus Diseases; Lung Neoplasms; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Soft Tissue Neoplasms; Splenic Neoplasms; Stomach Neoplasms; Treatment Outcome | 2016 |
18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2016 |
Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI.
Topics: Bone and Bones; Bone Density; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2017 |
Spindle Cell Sarcoma of the Iliac Vein on 18 F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iliac Vein; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2017 |
Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2008 |
Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging.
Topics: Diagnostic Imaging; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liposarcoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Epithelioid sarcoma with muscle metastasis detected by positron emission tomography.
Topics: Adult; Biopsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2008 |
The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; ROC Curve; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2008 |
Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2009 |
Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
F-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in left thigh intramuscular myxoma.
Topics: Aged; Biopsy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Mitosis; Myxoma; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Thigh; Tomography, X-Ray Computed | 2009 |
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Deoxycytidine; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Young Adult | 2010 |
Positron emission tomography in the diagnosis and management of intracranial germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pinealoma; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Soft Tissue Neoplasms | 2009 |
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2009 |
Contemporary imaging in sarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dioxoles; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome | 2009 |
Intense accumulation of 18F-FDG, not enhancement on MRI, helps to guide the surgical biopsy accurately in soft tissue tumors.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2009 |
FDG uptake in a rheumatoid nodule with imaging appearance similar to a malignant soft tissue tumor.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Rheumatoid Nodule; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2009 |
FDG PET-CT evaluation of granular cell tumor of the soft tissue.
Topics: Adenocarcinoma; Adult; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2010 |
Role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in the management of bone and soft-tissue metastases.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Young Adult | 2010 |
[Inflammatory myofibroblastic tumor of the lymph node with paraneoplastic thrombosis and eosinophilia].
Topics: Biopsy; Diagnosis, Differential; Eosinophilia; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Inguinal Canal; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasms, Muscle Tissue; Paraneoplastic Syndromes; Positron-Emission Tomography; Pulmonary Embolism; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Venous Thrombosis | 2010 |
Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Young Adult | 2010 |
FDG-PET/CT imaging of elastofibroma dorsi.
Topics: Aged; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2011 |
A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies; Soft Tissue Neoplasms; Thallium Radioisotopes; Young Adult | 2011 |
CT-guided percutaneous biopsy of a mass lesion in the upper presacral space: a sacral transneuroforaminal approach.
Topics: Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lumbosacral Region; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2012 |
Tenosynovial giant cell tumor of the thigh: positron emission tomography findings.
Topics: Adult; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Soft Tissue Neoplasms; Synovectomy; Synovial Membrane; Synovitis, Pigmented Villonodular; Thigh; Treatment Outcome | 2011 |
18F-FDG PET to identify soft tissue disease in multiple myeloma.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Soft Tissue Neoplasms | 2012 |
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Umbilical metastatic deposit from recurrent cholangiocarcinoma: F18-FDG PET-CT findings.
Topics: Aged; Cholangiocarcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Recurrence; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Umbilicus | 2011 |
Experimental model of naturally occurring post-radiation sarcoma: interest of positron emission tomography (PET) for early detection.
Topics: Animals; Biomarkers, Tumor; Cobalt Radioisotopes; Early Diagnosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hindlimb; Male; Mice; Mice, Nude; Models, Animal; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Sarcoma, Experimental; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2012 |
Clinical examination: losing the shine.
Topics: Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2012 |
Comment on "Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors" (Arch Orthop Trauma Surg. 2010 Jul; 130(7):819-27).
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2012 |
Round cell liposarcoma arising in the left foot: MRI and PET findings.
Topics: Aorta, Abdominal; Bone Neoplasms; Fluorodeoxyglucose F18; Foot; Humans; Liposarcoma; Liposarcoma, Myxoid; Lymph Node Excision; Magnetic Resonance Imaging; Male; Metatarsal Bones; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tarsal Bones | 2012 |
Subcutaneous and intramuscular metastases of cervix cancer detected with ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography after the chemoradiation therapy.
Topics: Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Proximal-type epithelioid sarcoma of the scrotum: 18F-FDG PET/CT imaging.
Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Scrotum; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2013 |
O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
Topics: Animals; Diagnosis, Differential; Fluorodeoxyglucose F18; Foot; Lymphadenitis; Lymphatic Metastasis; Lymphoma, T-Cell; Male; Methionine; Mice; Mice, Inbred BALB C; Neoplasm Staging; Neoplasm Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Tyrosine | 2002 |
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Regression Analysis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[F-18 FDG positron emission tomography in diagnosis and follow-up of patients with musculoskeletal tumors].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Radiotherapy, Adjuvant; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique.
Topics: Adolescent; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Osteosarcoma; Radiopharmaceuticals; Sodium Fluoride; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Child; Clavicle; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Muscle, Skeletal; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma.
Topics: Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thigh; Tomography, Emission-Computed | 2003 |
11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
18FDG PET scanning of benign and malignant musculoskeletal lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
[Biologic characterization of soft tissue sarcomes by positron emission tomography (initial results)].
Topics: Amino Acid Transport System A; Aminoisobutyric Acids; Blood Glucose; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Neoplasm Proteins; Oxygen Radioisotopes; Regional Blood Flow; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1998 |
[Positron emission tomography in a patient with Von Recklinghausen disease and left dorsal neurofibrosarcoma].
Topics: Adult; Back; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Neurofibrosarcoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Spinal Cord Compression; Tomography, Emission-Computed | 2003 |
Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurilemmoma; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2004 |
Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lower Extremity; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Orthopedic Procedures; Positron-Emission Tomography; Probability; Prospective Studies; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Upper Extremity | 2005 |
Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2005 |
Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2004 |
F-18 FDG PET imaging of metastases from soft tissue myoepithelioma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Myoepithelioma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Soft Tissue Neoplasms; Treatment Outcome | 2005 |
Paravertebral infection (phlegmon) demonstrated by FDG dual-head coincidence imaging in a patient with multiple malignancies.
Topics: Aged; Back Pain; Breast Neoplasms; Cellulitis; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lumbar Vertebrae; Melanoma; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Staphylococcal Infections | 2005 |
Unsuspected metastatic male breast nodule from synovial sarcoma detected by FDG PET.
Topics: Adult; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Synovial; Soft Tissue Neoplasms; Upper Extremity | 2005 |
Detection of multiple extracranial metastases from glioblastoma multiforme by means of whole-body [18F]FDG-PET.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Whole Body Imaging | 2005 |
F-18 FDG uptake associated with Elastofibroma dorsi.
Topics: Back; Fibroma; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms | 2005 |
Incidental detection of bilateral elastofibroma dorsi with F-18 FDG PET/CT.
Topics: Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subtraction Technique; Thoracic Wall; Tomography, X-Ray Computed | 2005 |
Myoepithelioma of soft tissue originating from the hand: 18F-FDG PET features.
Topics: Aged; Female; Fluorodeoxyglucose F18; Hand; Humans; Myoepithelioma; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2006 |
FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
Topics: Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Leg; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Whole Body Imaging | 2005 |
Clearance of unusual muscular uptake of F-18 FDG in the lower lumbar region on a repeat FDG-PET scan after oral chlorzoxazone intervention.
Topics: Administration, Oral; Adult; Artifacts; Buttocks; Chlorzoxazone; Female; Fluorodeoxyglucose F18; Humans; Lumbosacral Region; Muscle Relaxants, Central; Muscle Relaxation; Muscle, Skeletal; Neuroectodermal Tumors, Primitive, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2006 |
Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities.
Topics: Child, Preschool; Extremities; Fatal Outcome; Female; Fluorodeoxyglucose F18; Groin; Hand; Humans; Infant; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Remission Induction; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Survival Rate; Thigh; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Tear of plantar fascia and tibiocalcaneal ligament with positive F-18 FDG PET findings.
Topics: Ankle Injuries; Diagnosis, Differential; Fascia; Female; Fluorodeoxyglucose F18; Humans; Ligaments, Articular; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2006 |
F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Unsuspected bone and soft tissue lesions identified at cancer screening using positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Soft Tissue Neoplasms | 2007 |
Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Time Factors | 2006 |
PET monitoring of clear cell sarcoma of tendons and aponeuroses.
Topics: Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sarcoma, Clear Cell; Soft Tissue Neoplasms; Tendons; Tomography, X-Ray Computed | 2007 |
Localized nodular synovitis mimicking metastatic melanoma in a patient with metastatic melanoma on whole-body F-18 FDG PET/CT with MRI and pathological correlation.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Statistics as Topic; Synovitis; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Elastofibroma dorsi mimicking metastatic disease on fluorodeoxyglucose F-18 positron emission tomography in a breast cancer patient.
Topics: Aged; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Soft Tissue Neoplasms | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma, Myxoid; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Spinal Neoplasms; Survival Rate | 2007 |
F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Metastatic myxoid liposarcomas: imaging and histopathologic findings.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liposarcoma, Myxoid; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liposarcoma, Myxoid; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Soft Tissue Neoplasms | 2008 |
Increased F-18 FDG uptake on positron emission tomography/computed tomography imaging caused by plantar fibromatosis.
Topics: Aged; Fibroma; Fluorodeoxyglucose F18; Foot Diseases; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2008 |
Positron emission tomography with fluorine-18-fluorodeoxyglucose for the evaluation of therapeutic isolated regional limb perfusion in a patient with soft-tissue sarcoma.
Topics: Chemotherapy, Cancer, Regional Perfusion; Contrast Media; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Interferon-gamma; Leg; Liposarcoma; Male; Melphalan; Middle Aged; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1994 |
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.
Topics: Deoxyglucose; Diagnosis, Differential; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Deoxyglucose; Extremities; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Interferon-gamma; Male; Melphalan; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1996 |
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Muscle Neoplasms; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1998 |
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1998 |
A PET study of 18FDG uptake in soft tissue masses.
Topics: Case-Control Studies; Connective Tissue Diseases; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Time Factors; Tomography, Emission-Computed | 1999 |
FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Cell Division; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mitosis; Necrosis; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tyrosine | 1999 |
Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible?
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1999 |
Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Statistics, Nonparametric; Tomography, Emission-Computed | 2000 |
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
Topics: Adult; Aged; Bone Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoplasm Staging; Nuclear Proteins; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Suppressor Protein p53 | 2000 |
Positron emission tomography and the orthopaedic surgeon.
Topics: Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Prognosis; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2000 |
Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphate Isomerase; Humans; Male; Middle Aged; Musculoskeletal Diseases; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2000 |
Extensive F-18 FDG uptake in metastatic spindle cell carcinoma of the lung.
Topics: Aged; Carcinoma; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Soft Tissue Neoplasms; Thoracic Neoplasms; Tomography, Emission-Computed | 2001 |
Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posture; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Drug Monitoring; Epirubicin; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Paclitaxel; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Hibernoma: intense uptake seen on Tc-99m tetrofosmin and FDG positron emission tomographic scanning.
Topics: Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Leg; Lipoma; Liposarcoma; Magnetic Resonance Imaging; Male; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms | 2002 |
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2002 |
PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose.
Topics: Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
Noninvasive grading of musculoskeletal tumors using PET.
Topics: Bone Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscular Diseases; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1991 |
Metabolic imaging of human extremity musculoskeletal tumors by PET.
Topics: Adolescent; Adult; Child; Deoxyglucose; Female; Femoral Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Tumors; Histiocytoma, Benign Fibrous; Humans; Leg; Liposarcoma; Male; Middle Aged; Neurofibroma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1988 |